LipoFIT Analytic GmbH, a Regensburg, Germany-based diagnostics company, has raised €7m in funding.
Backers include SHS Gesellschaft für Beteiligungsmanagement, KfW Bankengruppe, Bayern Kapital and a private investor.
The company intends to use the funds to expand its diagnostic technology in its core business areas of human diagnostics as well as biogas and plant analytics.
Led by Managing Director Fritz Huber and COO Volker Pfahlert, LipoFIT uses nuclear magnetic resonance technology (NMR) to interpret human or other metabolic patterns in a short amount of time.
The company was founded in April 2004 as a spin-off of the Institute for Biophysics at the University of Regensburg.